Edwards Lifesciences (Irvine, CA) has announced that it has received FDA 510(k) approval for its ClearSight noninvasive monitor that, in conjunction with the company's EV1000 clinical platform, ...
Non-invasive blood pressure monitoring has undergone significant advancements in recent years, moving beyond conventional intermittent oscillometric methods. The development of continuous monitoring ...
Hosted on MSN
Edwards Lifesciences advances smart surgery monitoring with completed SMART TRENDS study
Edwards Lifesciences Corp. (EW) announced an update on their ongoing clinical study. Study Overview The “SMART TRENDS Study,” officially titled “Acumen HPI Smart Alerts and Smart Trends to Improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback